These 2 largest Washington DC Health Care Companies have seen their equal-company-weighted average stock market prices increase by an incredibly off-the-charts 1,080% for the six years and three and a half months from March 6, 2009 through the most recent date June 19, 2015.
The US Supreme Court is finalizing its position on King vs Burwell. If it rules to eliminate health insurance premium subsidies in 34 US States, the economic result on US Citizen Stock Market Portfolios will be a huge haircut, especially since just these 2 largest Washington DC Health Care Companies have experienced an average stock market price appreciation of a massive 11 times since March 6, 2009.
Below here are stock market prices on the most recent date June 19, 2015 and on March 6, 2009 for these 2 largest Washington DC Headquartered Health Care Companies, along with the related Stock Market Price Percentage Changes. The Companies are presented by Stock Market Capitalization:
Market | |||||
Price | |||||
% Change | |||||
Market | Market | 3-6-09 | |||
Price | Price | to | |||
Health Care Companies | HQs | 6-19-15 | 3-6-09 | 6-19-15 | |
$s | $s | ||||
Washington DC | |||||
The Advisory Board Company | Washington | DC | 53.89 | 7.12 | 657% |
Vanda Pharmaceuticals | Washington | DC | 12.86 | 0.80 | 1502% |
Average % Change all 2 Washington DC Health Care Companies With Market Cap > $500 Mil | 1,080% |